Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for T2 Biosystems, Inc. (TTOO : NSDQ)
 
 • Company Description   
T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets. It operates primarily in the United States. T2 Biosystems, Inc. is headquartered in Lexington, Massachusetts.

Number of Employees: 182

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.22 Daily Weekly Monthly
20 Day Moving Average: 1,701,897 shares
Shares Outstanding: 171.04 (millions)
Market Capitalization: $37.08 (millions)
Beta: 0.50
52 Week High: $1.48
52 Week Low: $0.20
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -49.48% -43.10%
12 Week -51.69% -46.90%
Year To Date -58.00% -49.82%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
101 HARTWELL AVENUE
-
LEXINGTON,MA 02421
USA
ph: 781-761-4646
fax: 781-357-3080
ir@t2biosystems.com http://www.t2biosystems.com
 
 • General Corporate Information   
Officers
John Sperzel - Chief Executive Officer; President and Chairman
John M. Sprague - Chief Financial Officer
Laura Adams - Director
Thierry Bernard - Director
Robin Toft - Director

Peer Information
T2 Biosystems, Inc. (ABMD)
T2 Biosystems, Inc. (DMDS)
T2 Biosystems, Inc. (CPWY.)
T2 Biosystems, Inc. (EQUR)
T2 Biosystems, Inc. (ECIA)
T2 Biosystems, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 89853L104
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 171.04
Most Recent Split Date: (:1)
Beta: 0.50
Market Capitalization: $37.08 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 1.31
EPS Growth
vs. Year Ago Period: -42.86%
vs. Previous Quarter: -42.86%
Sales Growth
vs. Year Ago Period: 4.00%
vs. Previous Quarter: 3.64%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -1,278.55
ROA
03/31/22 - -85.22
12/31/21 - -70.46
09/30/21 - -63.08
Current Ratio
03/31/22 - 2.64
12/31/21 - 3.80
09/30/21 - 4.78
Quick Ratio
03/31/22 - 2.24
12/31/21 - 3.46
09/30/21 - 4.35
Operating Margin
03/31/22 - -194.37
12/31/21 - -175.50
09/30/21 - -162.84
Net Margin
03/31/22 - -194.37
12/31/21 - -175.50
09/30/21 - -162.84
Pre-Tax Margin
03/31/22 - -194.37
12/31/21 - -175.50
09/30/21 - -162.84
Book Value
03/31/22 - -0.15
12/31/21 - -0.08
09/30/21 - -0.01
Inventory Turnover
03/31/22 - 4.52
12/31/21 - 4.59
09/30/21 - 5.14
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©